Abstract
Patients with severe head injury still carry a high risk of mortality and morbidity despite progress in clinical management (Frankowski et al. 1985; Alberico et al. 1987). Major causes of mortality in these patients are untreatable elevated intracranial pressure (ICP) in the early phase and septic-infectious complications during the later phase (Shackford et al. 1989). The importance of inflammatory events following head trauma even in the absence of systemic injuries has been recognized. Within a short period of time after hospitalization these patients show a depressed T-cell function, an anergy to delayed-type hypersensitivity skin testing, a decrease in the expression of interleukin-2 receptors on T-cells and, furthermore, a diminished in vitro interleukin-2 and γ-interferon production of T-cells as well as suppressed cell cytotoxicity (Quattrocchi et al. 1991; Hoyt et al. 1990). However, the depression of the peripheral immune system may be of a secondary nature and may be regulated by immunological events initiated as a result of the traumatic injury within the brain. In particular cytokines produced and released in the central nervous system (CNS) may play important roles in the pathophysiological events following brain trauma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarden LA, DeGroot EF, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411–1416
Aderka D, Le J, Vilcek J (1989) IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice. J Immunol 143:3517–3523
Akira S, Kishimoto T (1992) IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25–50
Alberico AM, Ward JD, Choi SC, Marmarou A, Young HF (1987) Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adult patients. J Neurosurg 67:648–656
Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J Immunol 149:2358–2366
Apfel SC, Lipton RB, Arezzo JC, Kessler JA (1991) Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 29:87–90
Araujo DM, Cotman CW (1993) Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial derived factors. Brain Res 600:49–55
Awatsuji H, Furukawa Y, Hirota M, Murakami Y, Nii S, Furukawa S, Hayashi K (1993) Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J Neurosci Res 34:539–545
Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049
Baggiolini M, Dewald B, Moser B (1992) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97–178
Banati RB, Gehrmann J, Schubert P, Kreutzberg GW (1993) Cytotoxicity of microglia. Glia 7:111–118
Banks WA, Ortiz L, Plotkin SR, Kastin AJ (1991) Human interleukin (IL) la, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259:988–996
Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2:241–248
Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15:74–80
Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewals B, Baggiolini M (1991) Phagocytosing neutrophils produce and release high amounts of neutrophil-activating peptide 1/interleukin-8. J Exp Med 173:771–774
Benveniste E (1995) The role of cytokines in multiple sclerosis/autoimmune encephalitis and other neurological disorders. In: Agarwal B, Puri R (eds) Human cytokines, their role in research and therapy. Blackwell, Boston/MA, pp 195–216
Bodmer S, Strommer K, Frei K, Siepl C, de Tribolet N, Heid I, Fontana A (1989) Immunosup-pression and transforming growth factor-β in glioblastoma. J Immunol 143: 3222–3229
Bowes MP, Zivin JA, Rothlein R (1993) Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 119:215–219
Carman-Krzan M, Vige X, Wise BC (1991) Regulation by Interleukin-1 of nerve growth factor mRNA expression in rat primary astroglial cultures. J Neurochem 56:636–643
Castell JV, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, Heinrich PC (1988) Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte- stimulating factor in the rat. Eur J Biochem 177:357–361
Castell JV, Gómez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC (1989) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237–239
Chan PH, Schmidley JW, Fishman RA, Longar SM (1984) Brain injury, edema, and vascular permeability changes induced by oxygen derived free redicals. Neurology (NY) 34:315–320
Clark JM (1974) Distribution of microglial clusters in the brain after head injury. J Neurol Neurosurg Psychiatry 37:463–474
Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A (1992) Differential expression of transforming growth factor- β1, -β2 and - β3 by glioblastoma cells, astrocytes and microglia. J Immunol 148:1404–1410
Cortez SC, Mcintosh TK, Noble LJ (1989) Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations. Brain Res 482:271–282
Cross EM, Chaffin WW (1982) Use of the binomial theorem in interpreting results of multiple tests of significance. Educ Psychol Measurem 42:25–34
Da Cuhna A, Jefferson JA, Jackson RW, Vitovic L (1993) Glial specific mechanisms of TGF- β1 induction by IL-1 in cerebral cortex. J Neuroimmunol 42:71–86
Dinarello CA (1991) Interleukin-1 and Interleukin-1 antagonism. Blood 77:1627–1652
Dixon CE, Lighthall JW, Anderson TE (1988) Physiologic, histopathologic, and cineradiographic characterization of a new fluid-percussion model of experimental brain injury in the rat. J Neurotrauma 5:91–104
Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML (1990) Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor a. Proc Natl Acad Sci USA 87:6758–6761
Eddieston M, Mucke L (1992) Molecular profile of reactive astrocytes-implication for their role in neurologic disease. Neuroscience 54:15–36
Fabry Z, Raine CS, Hart MN (1994) Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 15:218–224
Feldman Z, Contant CF, Pahwa R, Goodman JC, Robertson CS, Narayan RK, Grossman RG (1993) The relationship between hormonal mediators and systemic hypermetabolism after severe head injury. J Trauma 34:806–816
Foda MA, Marmarou A (1994) A new model of diffuse brain injury in rats. II. Morphological characterization. J Neurosurg 80:301–313
Frankowski RF, Annegers JF, Whitman S (1985) The descriptive epidemiology of head trauma in US. In: Becker DP, Povlishock JT (eds) Central nervous system trauma. Status report. National Institutes of Health, Bethesda, pp 89–122
Frei K, Leist TP, Meager A, Gallo P, Leppert D, Zinkernagel RM, Fontana A (1988) Production of B cell stimulatory factor-2 and interferon-γ in the central nervous system during viral meningitis and encephalitis. J Exp Med 168:449–453
Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 19:689–694
Frei K, Nadal D, Fontana A (1990) Intracerebral synthesis of tumor necrosis factor-α and interleukin-6 in infectious meningitis. Ann N Y Acad Sci 594:326–335
Frei K, Piani D, Pfister HW, Fontana A (1993) Immune-mediated injury in bacterial meningitis. Int Rev Exp Pathol 34:183–192
Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, Gupta A, van den Noort S, Gupta S (1989) The induction of intracellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin and Interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol 23:117–124
Furukawa Y, Tomioka N, Sato W, Satoyoshi E, Hayashi K, Furukawa S (1989) Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells. FEBS Lett 247:395–402
Gadient RA, Cron KC, Otten U (1990) Interleukin-1β and tumor necrosis factor-a synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 117:335–340
Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A (1989) Human immunodeficiency virus type I (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23:109–116
Gennarelli TA, Spielman GM, Langfitt TW, Gildenberg PL, Harrington T, Jane JA, Marshall LF, Miller JD, Pitts LH (1982) Influence of the type of intracranial lesion on outcome from severe head injury. J Neurosurg 56:26–32
Giulian D, Lachman LB (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228:4707–4717
Giulian D, Ingeman JE, George JK, Noponen M (1989) The role of mononuclear phagocytes in wound healing after traumatic brain injury to adult mammalian brain. J Neurosci 9:4416–1129
Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A (1993) Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 167:471–475
Hama T, Miymoto M, Tsukui H, Nishio C, Hatanaka H (1989) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett 104:340–344
Handa S (1992) Concentrations of interleukin-Iβ, interleukin-6, interleukin-8 and TNF-a in cerebrospinal fluid from children with septic or aseptic meningitis. Kurume Med J 39:257–265
Heumann R, Korshing S, Bandtlow C, Thoenen H (1987) Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection. J Cell Biol 104:1623–1631
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 84:5490–5494
Hosford D, Braquet P (1989) Potential role for platelet-activating factor and tumor necrosis factor in the immune impairments in shock and trauma. In: Faist E, Ninnemann J, Green D (eds) Immune consequences of trauma, shock and sepsis. Springer, Berlin, Heidelberg New York, pp 311–321
Hoyt DB, Ozkan N, Hansbrough JF, Marshall L, van Berkum-Clark M (1990) Head injury: an immunologic deficit in T-cell activation. J Trauma 30:759–767
Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989) Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74:1241–1244
Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484
Kim KS, Wass CA, Cross AS, Opal SM (1992) Modulaton of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res 11:293–298
Kitamura T, Ogorochi T, Miyajima A (1994) Multimeric cytokine receptors. Trends Endocrinol Metab 5:8–14
Kossmann T, Hans V, Imhof HG, Stocker R, Grob P, Trentz O, Morganti-Kossmann MC (1995) Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4:311–317
Kossmann T, Hans V, Imhof HG, Trentz O, Morganti-Kossmann MC (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 713:143–152
Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC (1997) Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab (in press)
Kromer LF (1986) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214–216
Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ (1991) Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918–2921
Kushner I, Mackiewicz A (1987) Acute phase proteins as disease markers. Dis Markers 5:1–11
Lacy M, Jones J, Whittemore SR, Haviland DL, Wetsel RA, Barnum SR (1995) Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J Neuroimmunol 61:71–78
Leppert D, Frei K, Gallo P, Yasargil MG, Hess K, Baumgartner G, Fontana A (1989) Brain tumors: detection of B-cell stimulatory factor-2/interleukin-6 in the absence of oligoclonal bands of immunoglobulins. J Neuroimmunol 24:259–264
Levi-Montalcini R, Angeletti PU (1968) Nerve growth factor. Physiol Rev 48:534–569
Lindholm D, Heumann R, Meyer M, Thoenen H (1987) Interleukin-1 regulates synthesis of nerve growth factor in non neuronal cells of rat sciatic nerve. Nature 330:658–659
Lindholm D, Hengerer B, Zafra F, Thoenen H (1990) Transforming growth factor-β1 stimulates the expression of nerve growth factor in the rat CNS. Dev Neurosci 1:9–12
Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H (1992) Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117:395–400
Lindsay RM (1979) Adult rat brain astrocytes support survival of both NGF-dependent and NGF-insensitive neurons. Nature 282:80–82
Logan A, Frautschy SA, Gonzalez AM, Sporn MB, Baird A (1992) Enhanced expression of transforming growth factor-β1 in the rat brain after localized cerebral injury. Brain Res 587:216–225
Lotem J, Shabo Y, Sachs L (1989) Regulation of megakaryocyte development by interleukin-6. Blood 74:1545–1551
Maimone D, Gregory S, Arnason BGW, Reder AT (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32:67–74
Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K (1994) A new model of diffuse brain injury in rats. I. Pathophysiology and biomechanics. J Neurosurg 80:291–300
Marshall LF, Marshall SB, Klauber MR, Clarck MVB, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes M (1991) A new classification of head injury based on computerized tomography. J Neurosurg 75:S14–S20
Martich GD, Danner RL, Ceska M, Suffredini AF (1991) Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 173:1021–1024
Marucha PT, Zeff RA, Kreutzer DL (1990) Cytokine regulation of IL-1β gene expression in the human polymorphonuclear leukocyte. J Immunol 145:2932–2937
Mastroianni CM, Paoletti F, Rivosecchi RM, Lancella L, Ticca F, Vullo V, Delia S (1994) Cerebrospinal fluid interleukin-8 in children with purulent bacterial and tuberculous meningitis. Pediatr Infect Dis J 13:1008–1010
Mathiesen T, Andersson B, Loftenius A, von Holst H (1993) Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 78:562–567
McClain CJ, Cohen D, Ott L, Dinarello C, Young B (1987) Ventricular fluid Interleukin-1 activity in patients with head injury. J Lab Clin Med 110:48–54
McClain C, Cohen D, Phillips R, Ott L, Young AB (1991) Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med 118:226–231
Morganti MC, Taylor J, Pesheva P, Schachner M (1990) Oligodendrocyte-derived Jl-160/180 extracellular matrix glycoproteins are adhesive or repulsive depending on the partner cell type and time of interaction. Exp Neurol 109:98–110
Morganti-Kossmann MC, Kossmann T (1995) The immunology of brain injury. In: Rothwell NJ (ed) Immune responses in the nervous system. Bios Scientific, Oxford, pp 159–187
Morganti-Kossmann MC, Kossmann T, Wahl SM (1992a) Cytokines and neuropathology. Trends Pharmacol Sci 13:286–291
Morganti-Kossmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM (1992b) Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β. J Neuroimmunol 39:163–174
Morita M, Kasahara T, Mukaida N, Matsushima K, Nagashima T, Nishizawa M, Yoshida M (1993) Induction and regulation of interleukin-8 and MCAF production in human brain tumor cell lines and brain tumor tissues. Eur Cytokine Netw 4:351–358
Mosmann T (1983) Rapid cholorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65:55–63
Mukaida N, Matsushima K (1992) Regulation of interleukin-8 production and the characteristics of the receptors for interleukin-8. Cytokines 4:41–53
Nieto-Sampedro M, Berman MA (1987) Interleukin-1 like activity in rat brain: sources, targets and effects of injury. J Neurosci Res 17:214–219
Nieto-Sampedro M, Lewis ER, Cotman CW, Manthorpe M, Skaper SD, Barbin G, Longo FM, Varon S (1982) Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science 217:860–861
Nijsten MWN, Hack CE, Helle M, ten Duis HJ, Klasen HJ, Aarden LA (1991) Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109:761–767
Nitta T, Allegretta M, Okumura K, Sato K, Steinman L (1992) Neoplastic and reactive human astrocytes express interleukin-8 gene. Neurosurg Rev 15:203–207
Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizu K, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T (1983) B cell growth factors and B cell differentiation factor from human T hybridomas: two distinct kinds of B cell growth factors and their synergism in B cell proliferation. J Exp Med 157:583–590
Pasinetti GM, Nichols NR, Tocco G, Morgan T, Laping N, Finch CE (1993) Transforming growth factor β1 and fibronectin messenger RNA in rat brain: responses to injury and cell type localization. Neuroscience 54:893–907
Patterson SL, Grady MS, Bothwell M (1993) Nerve growth factor and fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 605:43–49
Prehn JHM, Peruche B, Unsicker K, Krieglstein J (1993) Isoform specific effects of transforming growth factor-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J Neurochem 60:1665–1672
Quattrocchi KB, Frank EH, Miller CH, Amin A, Issel BW, Wagner FC Jr (1991) Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury. J Neurosurg 75:766–773
Racke MK, Jalbut SD, Cannella B, Albert PS, Raine CS, McFarlin DE (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146:3012–3017
Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163:319–328
Satoh T, Nakamura S, Taga T, Matsuda T, Hirano, Kishimoto T, Kairo Y (1988) Induction of neuronal differentiation in PC 12 cells by B cell stimulatory factor-2/interleukin-6. Mol Cell Biol 8:3546–3549
Seki T, Joh K, Oh-ishi T (1993) Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology 80:333–335
Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF (1990) Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144:129–135
Selmaj KW, Raine CS, Farooq M, Norton WT, Brosnan CF (1991) Cytokine cytotoxicity against oligodendrocytes apoptosis induced by lymphotoxin. J Immunol 147: 1522–1529
Shackford SR, Mackersie RC, Davis JW, Wolf PL, Hoyt DB (1989) Epidemiology and pathology of traumatic deaths occurring at a level I trauma center in a regionalized system: the importance of secondary brain injury. J Trauma 29:1392–1397
Shiga Y, Onodera H, Kogure K, Yamasaki Y, Yashima Y, Syozuhara H, Sendo F (1991) Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci Lett 125:110–112
Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Naeher-Noe M, Thoenen H (1990) Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of Interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 2:69–76
Stocker R, Bernays R, Kossmann T, Imhof H-G (1995) Monitoring and treatment of acute head injury. In: Goris RJA, Trentz O (eds) The integrated approach to trauma care. Springer, Berlin Heidelberg New York, pp 197–210
Tada M, Suzuki K, Yamakawa Y, Sawamura Y, Sakuma S, Abe H, van Meir E, de Tribolet N (1993) Human glioblastoma cells produce 77 amino acid interleukin-8. J Neuro Oncol 16:25–34
Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J Neuroimmunol 42:177–186
Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81–84
Terebuh PD, Otterness IG, Strieter RM, Lincoln PM, Danforth JM, Kunkel SL, Chensue SW (1992) Biologic and immunhistochemical analysis of interleukin-6 expression in vivo. Am J Pathol 140:649–657
Van Damme J, De Ley M, van Snick J, Dinarello C, Billiau A (1987) The role of interferon-β1 and the 26kDa protein (interferon-β2) as mediators of the antiviral effect of Interleukin-1 and tumor necrosis factor. J Immunol 139:1867–1872
Van den Brink WA, Marmarou A, Avezaat CJ (1990) Brain oedema in experimental closed head in jury in the rat. Acta Neurochir Suppl (Wien) 51:261–262
Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, Frei K, Fontana A, de Tribolet N (1992) Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297–4305
Van Snick J (1990) Interleukin-6: an overview. Annu Rev Immunol 8:253–278
Wahl SM (1994) Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J Clin Immunol 12:61–74
Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossmann MC, Kossmann T, Ellingsworth L, Mai UEH, Mergenhagen SE, Orenstein JM (1991) Macrophage- and astrocyte-derived transforming growth factor-β as a mediator of central nervous system dysfunction in acquired immunodeficiency syndrome. J Exp Med 173:981–991
Wiessner C, Gehrmann J, Lindholm D, Toepper R, Kreutzberg GW, Hossmann KA (1993) Expression of transforming growth factor-β1 and interleukin-lβ mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol (Berl) 86:439–446
Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A, Cuzner ML (1991) Detection of Interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 33:227–236
Yoshida K, Gage FH (1991) Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 538:118–126
Young AB, Ott LG, Beard D, Dempsey RJ, Tibbs PA, McClain CJ (1988) The acute-phase response of the brain-injured patient. J Neurosurg 69:375–380
Zhou D, Munster A, Winchurch RA (1991) Pathologie concentrations of interleukin-6 inhibit T cell responses via induction or activation of TGF-β. FASEB J 5:2582–2585
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kossmann, T. et al. (1997). Analysis of Immune Mediator Production Following Traumatic Brain Injury. In: Schlag, G., Redl, H., Traber, D. (eds) Shock, Sepsis, and Organ Failure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60698-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-60698-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64513-6
Online ISBN: 978-3-642-60698-4
eBook Packages: Springer Book Archive